EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sumitomo Pharma Co's enterprise value is $3,375 Mil.
Sumitomo Pharma Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $2,341 Mil. Therefore, Sumitomo Pharma Co's EV-to-Revenue for today is 1.44.
The historical rank and industry rank for Sumitomo Pharma Co's EV-to-Revenue or its related term are showing as below:
DNPUF'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.58 Med: 1.43 Max: 3.03
Current: 1.6
During the past 13 years, the highest EV-to-Revenue of Sumitomo Pharma Co was 3.03. The lowest was 0.58. And the median was 1.43.
DNPUF's EV-to-Revenue is ranked better than 66.21% of 1024
companies
in the Drug Manufacturers industry
Industry Median: 2.35
vs DNPUF: 1.60
The historical data trend for Sumitomo Pharma Co's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sumitomo Pharma Co's EV-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Sumitomo Pharma Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sumitomo Pharma Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sumitomo Pharma Co's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Sumitomo Pharma Co's EV-to-Revenue falls into.
Sumitomo Pharma Co's current Enterprise Value is $3,375 Mil.
Sumitomo Pharma Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,341 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sumitomo Pharma Co (OTCPK:DNPUF) EV-to-Revenue Explanation
Sumitomo Pharma Co's share price for today is $2.70.
Sumitomo Pharma Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.89.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sumitomo Pharma Co EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Sumitomo Pharma Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Sumitomo Pharma Co (Sumitomo Pharma Co) Business Description
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DNPUF has been successfully added to your 